Adachi et al. reviewed the publications using PubMed and Google Scholar for citations published after the outbreak of COVID-19, from December 2019 to July 2021, and identified six cases of JIA with COVID-19 during treatment with biologic DMARDs (anti-TNF-α or anti-IL-1β). The gene discussed is IL1B; the disease is COVID-19.